PRINCETON, New Jersey and UXBRIDGE, England, December 17 /PRNewswire/ --

- Product Developed Through Joint Venture Between Bristol-Myers Squibb and Gilead Sciences, the First of its Kind in HIV Treatment

The European Commission has granted marketing authorisation for ATRIPLA(R) 600 mg/200 mg/245 mg film-coated tablets. Each film-coated tablet contains 600 mg efavirenz, 200 mg emtricitabine and 245 mg tenofovir disoproxil (as fumarate). The decision means that ATRIPLA is formally approved for marketing in the 27 countries of the European Union, as well as in Norway and Iceland.

LONDON, December 17 /PRNewswire/ --

Endeavour International Corporation announced that its stock began trading today on the main market of the London Stock Exchange (LSE) under the ticker symbol ENDV.

"The listing on the LSE broadens our access to European markets which are more geographically focused on North Sea activities and the value our business strategy can add," said William L. Transier, chairman, chief executive officer and president. "With our growing management and operational presence in London and Oslo, it is fitting that we build closer ties with the local investment communities."

The company's shares will continue to trade on the American Stock Exchange under the symbol END.

MOSCOW, December 17 /PRNewswire/ --

Mechel OAO (NYSE: MTL), one of the leading Russian mining and metals companies, announces that the Company has acquired 49% of the shares of Toplofikatsia Rousse JSC (TPP "Rousse"), located in Rousse, Republic of Bulgaria. The acquisition is in line with Mechel's plans to develop the substantive power segment within the company's diversified business and enter new markets for its steam coal.

TORONTO, December 17 /PRNewswire/ --

- Free add-your-profile opportunity for colleges and universities on Facebook(R) Platform

Recent national surveys have found that 75% of college and university applicants are active Facebook users, and many discuss their plans for higher education using the social utility. SkoolPool(TM), a new application on Facebook Platform, offers a fast and effective way for institutions to share information with this key audience. With a SkoolPool membership, institutions get a profile page accessible through SkoolPool.com, SkoolPool on Facebook Platform, and on a Facebook Page designed and maintained by the Academica Group team.

DEERFIELD, Illinois, December 17 /PRNewswire/ --

- Third-Generation TRAb Assay Delivers Unprecedented Specificity for Diagnosing Graves' Disease

Siemens Medical Solutions Diagnostics (www.siemens.com/diagnostics) announced that it has signed an agreement with KreLo GmbH Medical Diagnostics for the rights to develop an automated stimulating TSH receptor antibody (TRAb) assay used in the differential diagnosis of Graves' disease. This agreement will make Siemens Medical Solutions Diagnostics the first in vitro diagnostics distributor of an automated TRAb assay featuring stimulating TRAb KreLo antibodies which are specific to the diagnosis of Graves' disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )